由百奥泰国际会议（大连）有限公司主办，国际组织工程与再生医学协会、韩国首尔大学融合技术院联合支持的第八届再生医学与干细胞大会将于2015年3月19-21日在韩国釜山国际会展中心举行，本届会议的主题是：点燃“不治之症”的希望之火。
再生医学与干细胞构成了一个巨大的医疗技术和服务行业,这个领域包含了多学科交流与合作,如基础科学、新兴技术和临床转化。在21世纪高科技领域中，巨大潜力的再生医学生物技术产业链将成为核心。进入第八个年头，国际再生医学与干细胞大会在不断成长，RMSC-2015（韩国）将为参与者提供对研究,战略业务规划,决策和未来的职业发展有用的资源、信息和建议。
再生医学和干细胞大会已经成功举办过七届，本次会议包含：全球干细胞经济，市场，政策，法规和伦理问题、干细胞前沿科学、干细胞技术、干细胞和再生医学、干细胞组织工程、干细胞药物开发和发展、干细胞产品再生医学资金和投资等七个研讨专题，涵盖36个研讨向。
我们真诚地希望您参加本次会议，在2015年3月与新朋旧友共聚韩国釜山，和大师同行，与精英为伍。通过面对面的交流，您将找到新的合作伙伴，发现新的思路，促进国际合作与交流。（目前，部分科技论坛仍有演讲机会，大会征集英文论文摘要、英文演讲、英文项目海报、企业展位，欢迎精英参会并诚邀赞助单位！）
2015第八届再生医学与干细胞大会会务组
联系人：Vicki Qian
电话：0411-84799609-801
电子邮件：vicki@bitconferences.cn
地址：大连市高新园区汇贤园1号
邮编：116025
大会网站：http://www.bitcongress.com/RMSC-Korea2015/cn/default.asp
会议报名：http://www.bitcongress.com/RMSC-Korea2015/cn/zhuce.asp
大会议题（会议语言为全英文，无同声传译）：
Tentative Program Layout
Stream 1: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum of RMSC 2015-Korea
Part 3: Global Stem Cell Economy, Market, Policy, Strategy, Legal and Ethic Issues
Session P 3-1: The Development Trend of Global Stem Cell Economy and Market
Session P 3-2: Ethic, Safety Issues and Social Acceptance of Stem Cell Research
Session P 3-3: Global Stem Cell Policy, Strategy and Legal Issues
Stream 2: Thematic Scientific Program
Module 1: Frontier Science of Stem Cell
Session 101: Genomics and Epigenomics of Stem Cells
Session 102: Systems Biology of Stem Cells
Session 103: Mitochondrial DNA, Mitochondrial Diseases and Stem Cell
Session 104: Cell Cycle Control, Checkpoint and Stem Cell Biology
Session 105: Stem Cell Lineage, Derivation and Differentiation
Session 106: Nuclear Cloning and Epigenetic Reprogramming
Session 107: Reproductive and Developmental Biology
Session 108: Neural Stem Cells and Development
Session 109: Cancer Stem Cells
Session 110: Stem Cells and Gene Therapy
Session 111: Embryonic-like Stem Cells and Primo Vascular System
Module 2: Stem Cells Technologies
Session 201: Cell Based Technologies
Session 202: Stem Cell Banking
Session 203: Stem Cell Sourcing, Preservation and Cryopreservation
Session 204: Imaging, Modeling and Monitoring Technologies
Session 205: Stem Cell Extraction, Expansion, and Stage Stem Cell Products
Module 3: Stem Cell and Regenerative Medicine
Session 301: Neural Degenerative Diseases, Stroke and CNS Repairing
Session 302: Bone, Cartilage, Artificial Ligaments and Tendon Tissue Repairing
Session 303: Stem Cell in Eye Disease and Plastic Surgery
Session 304: Cardiovascular, Cardiac Tissue Regeneration or Repair and Vascular Disease
Session 305: Hematopoietic Stem Cell Transplantation and Bone Marrow Transplantation
Session 306: Stem Cell Therapy for Autoimmune Diseases
Session 307: Digestive Respiratory and Urologic Tissues and Organ Regeneration
Module 4: Stem Cell Tissues Engineering
Session 401: Biomechanics Stem Cell and Tissue
Session 402: Computer-Aided Tissue Engineering
Session 403: Biofabrication and Tissue Engineering
Session 404: Cell Culture, Bioreactor Design, Scaffolds System and Bioprocessing
Session 405: Synthetic Materials-Biomaterials and Scaffolds
Session 406: Micro and Nanotechnologies in Engineering Stem Cells and Tissues
Session 407: ECM Biology, Functions, and Cell-ECM Interaction in Tissue Engineering
Module 5: Stem Cells in Drug Discovery and Development
Stream 3: Workshop for Best Industrial Practice Symposia
Module 6: Stem Cell Products Regenerative Medicine Funding and Investment
Stream 4: Business & Social Events
Event 1: Match Making, Career Fair, and Partnership
Event 2: Business Development Roundtable and New Product Briefing
Event 3: Posters and Exposition
Event 4: Welcome Banquet
Event 5: Field Trip to Stem Cell Corporation
Event 6: Korea Impression Tech-Tour
著名演讲人：
Dr. Stephen Minger, Chief Scientist, Cellular Sciences, GE Healthcare Life Sciences, UK
Dr. Robert Deans, Executive Vice President, Regenerative Medicine, Athersys, Inc, USA
Dr. Mariusz Z. Ratajczak, Editor-in-Chief, the Central European Journal of Biology; Professor, James Graham Brown Cancer Center, University of Louisville, USA
Dr. Gilson Khang, TERMIS-AP Continental Chair-Elect; Co-Editor-in-Chief, International Journal of Tissue Regenerations; Professor, Chonbuk National University, South Korea
Dr. Anton C. Krucky, President & CEO, Tissue Genesis, Inc., USA
Dr. Johan Hyllner, Chief Scientific Officer, Cell Therapy Catapult, UK
Dr. Wojtek??Auerbach, Senior Director, Regeneron?Pharmaceuticals, USA
Dr. Rahul Aras, President, Juventas Therapeutics, USA
Dr. Fritz Lahrtz, Patentanwalt / European Patent Attorney, Isenbruck B?sl H?rschler LLP, Germany
Dr. Anthony E. Ting, Senior Director, Regenerative Medicine, Head, Cardiovascular and Pulmonary R&D, Athersys, Inc., USA
Dr. Nabil Hagag, Professor, State University of New York At Stony Brook, USA
Dr. Laura Riboni, Professor, University of Milan, Italy
Dr. Alexander Kharazi, Chief Technology Officer, Stemedica Cell Technologies, Inc., USA
Dr. Anand Gadre, Director, Stem Cell Instrumentation Foundry, University of California, USA
Dr. Ralf Huss, Chief Scientific Officer, apceth GmbH & Co. KG, Germany
Dr. Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Ltd, Australia
Dr. Senyon Choe, Professor, Joint Center for biosciences & Salk Institute, USA
Dr. Julie Anderson, Professor, Buck Institute for Age Research, USA
Dr. Edda Tobiasch, Professor, Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Germany
Dr. Anand S. Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research, USA
Dr. John Yu, Professor and Director, Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital, Chang Gung University; Founder, Taiwan Society for Stem Cell Research, Taiwan
Dr. Alain Vertes, Managing Director, NxR Biotechnologies, Switzerland; Sloan Fellow, London Business School, UK
Dr. Jose R. Nunez, Professor, WHO, Switzerland
Dr. Young-Ho Lee, Chairman, Department of Pediatrics, Hanyang University Medical Center, South Korea
Dr. Kwang-Sup Soh, Professor, Seoul National University, South Korea
Dr. Sang-Suk Lee, Professor & Dean, College of Health and Science, Sangji University, Wonju, South Korea
Dr. Yang-Sook Chun, Professor, Epigenomics & Microenvironment Remodeling Laboratory, Seoul National University College of Medicine, South Korea
韩国旅游
釜山是韩国第二大城市，拥有人口360万，是韩国最大港口城市也是世界最繁忙的海港之一。釜山位于朝鲜半岛东南端的海岸上，北面、西面靠着低山，南面、东面临海，其气候温和舒适，很少有过热或过冷的天气，是一个风景旖旎秀丽的海滨城市。无论是其山川景色还是海洋风光都是理想的观光之地。其主要的旅游名胜有寺庙，各种殿阁等，疗养胜地有大的海水浴场、岛屿和海岸公园多处，其中近海的影岛是游人不可不去的风光区。每年3月。釜山会举办国际表演艺术节。釜山是个国际会议中心，是2002年亚运会和2005年APEC的承办城市，已经发展为多种文化共存的国际性现代大都市。旅游线路：http://www.bitcongress.com/RMSC-Korea2015/cn/TechTour.asp
